Join
Live feed
·
INSIDERFilingvia Quantisnow
Ionis Pharmaceuticals Inc. logo

EVP, Chief Development Officer Kordasiewicz Holly B. converted options into 11,119 shares and sold $313,308 worth of shares (4,141 units at $75.66), increasing direct ownership by 90% to 14,718 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
IONS· Ionis Pharmaceuticals Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track IONS (Ionis Pharmaceuticals Inc.) and more on Quantisnow.

EVP, Chief Development Officer Kordasiewicz Holly B. converted options into 11,119 shares and sold $313,308 worth of shares (4,141 units at $75.66), increasing direct ownership by 90% to 14,718 units (SEC Form 4) | Quantisnow